Effect of developmental exposure to bisphenol A on steroid hormone and vitamin D3 metabolism

Jae Kwan Kim1, Adnan Khan1, Seongha Cho1

  • 1College of Pharmacy, Korea University, Sejong, 30019, Republic of Korea.

Chemosphere
|September 25, 2019
PubMed

Insights

Bisphenol A (BPA) exposure alters metabolism in rats, impacting steroid hormones and vitamin D. These BPA-induced metabolic shifts are dose- and sex-specific, potentially explaining developmental problems.

Area of Science:

  • Environmental toxicology
  • Metabolomics
  • Developmental biology

Background:

  • High exposure to bisphenol A (BPA) is linked to developmental problems in children.
  • Understanding the mechanisms of BPA-induced developmental toxicity is crucial.

Purpose of the Study:

  • To elucidate the metabolic mechanisms underlying BPA-mediated developmental toxicity.
  • To investigate dose- and sex-specific effects of BPA exposure.
  • To analyze metabolic shifts in plasma and urine following BPA administration.

Main Methods:

  • High-resolution metabolomics was used to analyze plasma and urine from rats exposed to BPA.
  • Rats were administered 5 different BPA doses from post-natal day 9 for 91 days.
  • Multivariate statistical analysis was employed to identify dose- and sex-specific effects.

Main Results:

  • Metabolic shifts were significantly altered at 5, 50, and 250 mg BPA/kg bw/day, showing non-monotonic and monotonic dose-response relationships in plasma and urine, respectively.
  • Perturbations in steroid hormone biosynthesis were associated with dose- and sex-specific BPA effects, with down-regulation of steroid hormones at the highest dose.
  • BPA exposure altered vitamin D3 metabolism, increasing urinary excretion and decreasing blood concentration, suggesting a link to neurodevelopmental disorders.

Conclusions:

  • BPA induces dose- and sex-specific metabolic alterations.
  • Metabolic perturbations, particularly in steroid hormone and vitamin D3 pathways, are implicated in BPA-induced developmental problems.
  • Observed sex differences in metabolic response, with females being more affected, may relate to early puberty onset.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
7.6K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
525
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.1K